Centessa Pharmaceuticals plc (ADR) share price logo

Centessa Pharmaceuticals plc (ADR)

NASDAQ: CNTA

$40.50

+0.32

(+0.80%)

as on

Bell Icon

This instrument is not available for trading on the INDmoney app on 23 Jun 2026

Centessa Pharmaceuticals plc (ADR) Stock Performance

as on June 24, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $40.00
    $40.55
    downward going graph

    1.23%

    Downside

    0.12%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $12.78
    $40.56
    downward going graph

    68.44%

    Downside

    0.15%

    Upside

    downward going graph

Centessa Pharmaceuticals plc (ADR) share price movements today

Previous Close
$40.18
Open
$40.18
Volume
8.6M
Day's Low - High
$40.00 - $40.55
52 Week Low - High
$12.78 - $40.56

Centessa Pharmaceuticals plc (ADR) Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Centessa Pharmaceuticals plc (ADR) Stock Fundamentals & Key Indicators

Check Centessa Pharmaceuticals plc (ADR) market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

0.00%

Centessa Pharmaceuticals plc (ADR) vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Centessa Pharmaceuticals plc (ADR) with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Centessa Pharmaceuticals plc (ADR) image
Centessa Pharmaceuticals plc (ADR)
BUY$-NANA0.00%NA
Alnylam Pharmaceuticals Inc. image
Alnylam Pharmaceuticals Inc.
BUY$38.9B73.15%73.0312.55%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$124.7B147.81%29.1635.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$66.4B13.12%15.4629.65%0.58%

Analyst Recommendation on Centessa Pharmaceuticals plc (ADR) Stock

Based on 11 analysts

BUY

81.82%

Buy

18.18%

Hold

0.00%

Sell

Based on 11 analysts, 81.82% of analysts recommend a 'BUY' rating for Centessa Pharmaceuticals plc (ADR). Average target price of $44.17

Centessa Pharmaceuticals plc (ADR) Share Price Target

Get share price movements and forecasts by analysts on Centessa Pharmaceuticals plc (ADR).

What analysts predicted

8.31%UPSIDE

Target Price

$44.17

Current Price

$40.5

Analyzed by

11 Analysts

Target

$44.17

Centessa Pharmaceuticals plc (ADR) target price $44.17, a slight upside of 8.31% compared to current price of $40.5. According to 11 analysts rating.

Centessa Pharmaceuticals plc (ADR) Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
6
-
-
-
0
15
-
-
-
-
Gross Profit
6
0
0
0
0
15
0
-
-
0
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-36
-38
-43
-42
-111
-26
-50
-54
-66
-79
Net Profit Margin
-537.53%
0.00%
0.00%
0.00%
-11691.13%
-174.23%
0.00%
0.00%
0.00%
0.00%

Centessa Pharmaceuticals plc (ADR) Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
6
-
15
Gross Profit
-
-
0
6
0
15
Operating Income
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
Net Income
-5
-10
-216
-151
-235
-197
Net Profit Margin
0.00%
0.00%
0.00%
-2204.65%
0.00%
-1316.88%

Global Institutional Holdings in Centessa Pharmaceuticals plc (ADR)

Funds
Holdings
EcoR1 Capital, LLC
3.88%
TCG Crossover Management, LLC
2.77%
Morgan Stanley - Brokerage Accounts
2.76%
Point72 Asset Management, L.P.
1.93%
First Light Asset Management, LLC
1.01%
See all

Centessa Pharmaceuticals plc (ADR) News & Key Events

  • img

    Today's Timeline - 01 April

    Wed, 07:36 PM

    -

    Eli Lilly announces acquisition of Centessa Pharmaceuticals for $38 per share, totaling approximately $6.3 billion.

Insights on Centessa Pharmaceuticals plc (ADR)

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, CNTA has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, CNTA stock has moved up by 43.5%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, CNTA has outperformed top 5 stocks with highest market-cap in its industry

About Centessa Pharmaceuticals plc (ADR)

Centessa Pharmaceuticals plc is a clinical-stage pharmaceutical company. The Company is developing a new class of potential therapies within its orexin receptor 2 (OX2R) agonist program for the treatment of excessive daytime sleepiness (EDS), impaired attention, cognitive deficits, fatigue and other symptoms across neurological, neurodegenerative and neuropsychiatric disorders. It also has an early-stage immuno-oncology program focused on its LockBody technology platform. Its OX2R agonist pipeline includes ORX750, its advanced OX2R agonist development candidate, and ORX142, ORX489 and OX2R agonists in preclinical development. Its ORX750, an investigational, orally administered, highly potent and selective OX2R agonist, is in a Phase IIa study of participants with narcolepsy type 1 (NT1), NT2 and idiopathic hypersomnia (IH). ORX142 is the second OX2R agonist development candidate being advanced for the treatment of neurological and neurodegenerative disorders and other symptoms.
OrganisationCentessa Pharmaceuticals plc (ADR)
E-voting on sharesClick here to vote

FAQs

What is Centessa Pharmaceuticals plc (ADR) share price today?

Centessa Pharmaceuticals plc (ADR) share price today is $40.5 as on at the close of the market. Centessa Pharmaceuticals plc (ADR) share today touched a day high of $40.55 and a low of $40.

What is the 52 week high and 52 week low for Centessa Pharmaceuticals plc (ADR) share?

Centessa Pharmaceuticals plc (ADR) share touched a 52 week high of $40.56 on and a 52 week low of $12.78 on . Centessa Pharmaceuticals plc (ADR) stock price today i.e. is closed at $40.5,which is 0.15% down from its 52 week high and 216.90% up from its 52 week low.

How to invest in Centessa Pharmaceuticals plc (ADR) Stock (CNTA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Centessa Pharmaceuticals plc (ADR) on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Centessa Pharmaceuticals plc (ADR) Shares that will get you 0.0370 shares as per Centessa Pharmaceuticals plc (ADR) share price of $40.5 per share as on June 24, 2026 at 8:46 am IST.

What is the minimum amount required to buy Centessa Pharmaceuticals plc (ADR) Stock (CNTA) from India?

Indian investors can start investing in Centessa Pharmaceuticals plc (ADR) (CNTA) shares with as little as ₹94.66 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.60 in Centessa Pharmaceuticals plc (ADR) stock (as per the Rupee-Dollar exchange rate as on ). Based on Centessa Pharmaceuticals plc (ADR) share’s latest price of $40.5 as on June 24, 2026 at 8:46 am IST, you will get 0.2469 shares of Centessa Pharmaceuticals plc (ADR). Learn more about fractional shares .